Polio-Rhinovirus Promising for Malignant Glioma Patients

THURSDAY, July 12, 2018 -- Intratumoral infusion of recombinant nonpathogenic polio-rhinovirus chimera (PVSRIPO) can be delivered safely and is tied to higher survival rates than those of historical controls, according to a study published in the...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news